Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![visufinance Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1669431679834902528.png) VisuFinance [@visufinance](/creator/twitter/visufinance) on x XXX followers
Created: 2025-07-14 12:11:59 UTC

$CORT - Corcept Therapeutics seeks FDA approval for relacorilant to treat platinum-resistant ovarian cancer.

Read more on

![](https://pbs.twimg.com/media/Gv0TFVsXoAA91aB.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944731598294749187/c:line.svg)

**Related Topics**
[corcept therapeutics](/topic/corcept-therapeutics)
[$cort](/topic/$cort)

[Post Link](https://x.com/visufinance/status/1944731598294749187)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

visufinance Avatar VisuFinance @visufinance on x XXX followers Created: 2025-07-14 12:11:59 UTC

$CORT - Corcept Therapeutics seeks FDA approval for relacorilant to treat platinum-resistant ovarian cancer.

Read more on

XXX engagements

Engagements Line Chart

Related Topics corcept therapeutics $cort

Post Link

post/tweet::1944731598294749187
/post/tweet::1944731598294749187